Skip to content
★ Sign in to follow
Total declarations
13
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€570k

Latest filing published 09 Aug 2021 for Jazz Pharmaceuticals plc, €212k.

Filing timeline

BuySale
Elmar Schnee

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

Elmar Schnee: trading record in brief

All filings by Elmar Schnee on record concern Jazz Pharmaceuticals plc. In total, 13 filings cover trades dated from 7 August 2014 to 5 August 2021.

The open-market record consists of 6 sales worth €570k, with no purchase. Besides market trades, the filings include 7 share grants. Since January 2021: no purchases and 1 sale on the market.

The latest filing, published on 9 August 2021, reports an open-market sale of €212k in Jazz Pharmaceuticals plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Elmar Schnee

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total

13 of 13 declarations